Paul L. Berns, SEE REMARKS: Neumora Therapeutics NMRA Sell · Filed 25/02/20

Trade details

Type: Insider sale
Amount: $23,441.99
Shares · price: 13,871 sh · $1.69 a share
Held after: 7,405,004 sh
Stock: Neumora Therapeutics NMRA
Person: Paul L. BernsSEE REMARKS
Trade date: 25/02/18
Filed: 25/02/20
Days to filing: 2 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Neumora Therapeutics trades, last 26 weeks

What else happened in Neumora Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Paul L. Berns's recent trades

Paul L. BernsDirector
BuyKardigan
Buy
Kardigan
KARD
$20M
1,250,000 sh
$20M
Filed 06/24
Traded 06/22
Paul L. Berns10% Owner
BuyLyell Immunopharma
Buy
Lyell Immunopharma
LYEL
$12.5M
488,090 sh
$12.5M
Filed 03/09
Traded 03/06
Paul L. BernsSEE REMARKS
SellNeumora Therapeutics
Sell
Neumora Therapeutics
NMRA
$34.5K
9,819 sh
$34.5K
Filed 02/19
Traded 02/17
Paul L. BernsOfficer
Planned saleNeumora Therapeutics
Planned sale
Neumora Therapeutics
NMRA
$34.5K
9,819 sh
$34.5K
Filed 02/17
Traded 02/17
Paul L. BernsOfficer
Planned sale10b5-1 planNeumora Therapeutics
Planned sale10b5-1 plan
Neumora Therapeutics
NMRA
$23.5K
13,871 sh
$23.5K
Filed 25/02/18
Traded 25/02/18

Paul L. Berns, Officer — sold $23.4K of Neumora Therapeutics NMRA · 0.2% of holdings · 10b5-1 plan | Whalegun